ETOPOPHOS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Etoposide Phosphate.
| Product ID | 0015-3404_23c5d977-f8be-4f5b-b810-9a0ec0866925 |
| NDC | 0015-3404 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ETOPOPHOS |
| Generic Name | Etoposide Phosphate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2009-06-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020457 |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | ETOPOSIDE PHOSPHATE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2009-06-01 |
| Marketing End Date | 2021-04-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020457 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-06-01 |
| Marketing End Date | 2021-04-30 |
| Ingredient | Strength |
|---|---|
| ETOPOSIDE PHOSPHATE | 100 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0015-3404 | ETOPOPHOS | etoposide phosphate |
| 61269-410 | ETOPOPHOS | etoposide phosphate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ETOPOPHOS 74179774 1757537 Live/Registered |
CHEPLAPHARM ARZNEIMITTEL GMBH 1991-06-25 |